I agree that this site is using cookies. You can find further informations here.
X
Westin, Shannon N
120  results:
OpenAccess-fulltext X
Search for persons X
?
1

Predictors of Oncologic Outcome in Patients Receiving Phase..:

Son, Ji ; Lin, Heather Y ; Fu, Siqing...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9888522/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
2

Selinexor in combination with weekly paclitaxel in patients..:

Westin, Shannon N ; Fu, Siqing ; Tsimberidou, Apostolia...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797438/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
3

Combination of EphA2- and Wee1-Targeted Therapies in Endome..:

Dasari, Santosh K ; Joseph, Robiya ; Umamaheswaran, Sujanitha...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962847/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
4

Low-grade serous ovarian cancer: expert consensus report on..:

Grisham, Rachel N ; Slomovitz, Brian M ; Andrews, Nicole...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511962/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
5

PRMT blockade induces defective DNA replication stress resp..:

Li, Yang ; Dobrolecki, Lacey E ; Sallas, Christina...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10772459/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
6

Exploiting metabolic vulnerabilities after anti-VEGF antibo..:

Glassman, Deanna ; Kim, Mark S ; Spradlin, Meredith...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941132/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
7

Androgen receptor blockade promotes response to BRAF/MEK-ta..:

Vellano, Christopher P ; White, Michael G ; Andrews, Miles C...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071594/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
8

Distinct molecular and immune hallmarks of inflammatory art..:

Kim, Sang T ; Chu, Yanshuo ; Misoi, Mercy...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005525/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
9

Targeting the ALK–CDK9-Tyr19 kinase cascade sensitizes ovar..:

Chu, Yu-Yi ; Chen, Mei-Kuang ; Wei, Yongkun...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586872/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
10

ADJUVANT THERAPY IN WOMEN WITH EARLY STAGE UTERINE SEROUS C..:

Kurnit, Katherine C ; Nobre, Silvana Pedra ; Fellman, Bryan M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278585/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
11

A Randomized, Phase III Trial to Evaluate Rucaparib Monothe..:

Monk, Bradley J ; Parkinson, Christine ; Lim, Myong Cheol...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746782/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
12

Targeting the DDR beyond PARP inhibitors: Novel agents and ..:

Ngoi, Natalie YL ; Westin, Shannon N ; Yap, Timothy A
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9371461/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
13

Molecular Profiles of Serum-Derived Extracellular Vesicles ..:

Zhao, Li ; Corvigno, Sara ; Ma, Shaolin...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330879/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
14

A Randomized, Phase III Trial to Evaluate Rucaparib Monothe..:

Monk, Bradley J ; Parkinson, Christine ; Lim, Myong Cheol...
Journal of Clinical Oncology, 0732-183X, 2022, 40:34, s. 3952-3964.  , 2022
Link: http://urn.kb.se/resolve..
 
?
15

Intensity-Modulated Radiation Therapy Reduces Patient-Repor..:

Yeung, Anamaria R ; Deshmukh, Snehal ; Klopp, Ann H...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9851703/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
1-15